Altered diurnal pattern of steroid hormones in relation to various behaviors, external factors and pathologies: A review

Physiology and Behavior

Volumn 164, Issue , 2016, Pages 68-85

  Collomp, K ^a,b,c   Baillot, A ^d,e   Forget, H ^d   Coquerel, A ^c,f   Rieth, N ^a,b   Vibarel Rebot, N ^a,b  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c Agence Francaise de Lutte contre le Dopage   (France)

^d UNIVERSITÉ DU QUÉBEC EN OUTAOUAIS   (Canada)

^e Hopital Montfort Hospital   (Canada)

^f UNIVERSITÉ DE CAEN   (France)

Author keywords

Behavior; Circadian rhythm; Cortisol; DHEA; Pathology; Physical exercise; Testosterone

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CAFFEINE; CANNABINOID; CANNABIS; CATHA EDULIS EXTRACT; GLUCOCORTICOID; HYDROCORTISONE; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PSYCHOTROPIC AGENT; RHODIOLA EXTRACT; STEROID HORMONE; STRESS HORMONE; TESTOSTERONE; STEROID;

ALZHEIMER DISEASE; ANOREXIA NERVOSA; AUTISM; BEHAVIOR; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC STRESS; CIRCADIAN RHYTHM; CUSHING SYNDROME; DEPRESSION; EXERCISE; FIBROMYALGIA; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; JET LAG; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARKINSON DISEASE; PATHOLOGY; PHYSICAL ACTIVITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SENILE DEMENTIA; SLEEP DEPRIVATION; ANIMAL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; EXERCISE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MENTAL DISORDERS; NEOPLASMS; PITUITARY-ADRENAL SYSTEM; SLEEP DEPRIVATION; STEROIDS;

EID: 84971328570     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2016.05.039     Document Type: Review

References (353)

1. Collomp R., Labsy Z., Zorgati H., Prieur F., Cottin F., Do M.C., Gagey O., Lasne F., Collomp K. Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone. Endocrine 2014, 46:668-671.
2. Edwards S., Evans P., Hucklebridge F., Clow A. Association between time of awakening and diurnal cortisol secretory activity. Psychoneuroendocrinology 2001, 26:613-622.
3. Hucklebridge F., Hussain T., Evans P., Clow A. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 2005, 30:51-57.
4. Kraemer W.J., Loebel C.C., Volek J.S., Ratamess N.A., Newton R.U., Wickham R.B., Gotshalk L.A., Duncan N.D., Mazzetti S.A., Gómez A.L., Rubin M.R., Nindl B.C., Häkkinen K. The effect of heavy resistance exercise on the circadian rhythm of salivary testosterone in men. Eur. J. Appl. Physiol. 2001, 84:13-18.
5. Passelergue P., Robert A., Lac G. Salivary cortisol and testosterone variations during an official and a simulated weight-lifting competition. Int. J. Sports Med. 1995, 16:298-303.
6. Clow A., Hucklebridge F., Thorn L. The cortisol awakening response in context. Int. Rev. Neurobiol. 2010, 93:153-175.
7. Labsy Z., Prieur F., Le Panse B., Do M.C., Gagey O., Lasne F., Collomp K. The diurnal patterns of cortisol and dehydroepiandrosterone in relation to intense aerobic exercise in recreationally trained soccer players. Stress 2013, 16:261-265.
8. Oskis A., Loveday C., Hucklebridge F., Thorn L., Clow A. Diurnal patterns of salivary cortisol across the adolescent period in healthy females. Psychoneuroendocrinology 2009, 34:307-316.
9. Oskis A., Clow A., Thorn L., Loveday C., Hucklebridge F. Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescents. Stress 2012, 15:110-114.
10. Lac G., Chamoux A. Do circannual rhythm of cortisol and testosterone interfere with variations induced by other events?. Ann. Endocrinol. 2006, 67:60-63.
11. Lovallo W.R., Farag N.H., Vincent A.S. Use of a resting control day in measuring the cortisol response to mental stress: diurnal patterns, time of day, and gender effects. Psychoneuroendocrinology 2010, 35:1253-1258.
12. Thorn L., Evans P., Cannon A., Hucklebridge F., Clow A. Seasonal differences in the diurnal pattern of cortisol secretion in healthy participants and those with self-assessed seasonal affective disorder. Psychoneuroendocrinology 2011, 36:816-823.
13. Guimard A., Prieur F., Baillot A., Amiot V., Mongeois E., Barrande M., Lasne F., Collomp K. Effect of obesity on diurnal patterns of testosterone and dehydroepiandrosterone in male subjects. Sci. Sports 2013, 28:331-334.
14. Liening S.H., Stanton S.J., Saini E.K., Schultheiss O.C. Salivary testosterone, cortisol, and progesterone: two-week stability, interhormone correlations, and effects of time of day, menstrual cycle, and oral contraceptive use on steroid hormone levels. Physiol. Behav. 2010, 99:8-16.
15. Vibarel-Rebot N., Rieth N., Lasne F., Jaffré C., Collomp K. Oral contraceptive use and saliva diurnal pattern of metabolic steroid hormones in young healthy women. Contraception 2015, 91:245-247.
16. Björntorp P. Alterations in the ageing corticotropic stress-response axis. Novartis Found. Symp. 2002, 242:46-58.
17. Matchock R.L., Dorn L.D., Susman E.J. Diurnal and seasonal cortisol, testosterone, and DHEA rhythms in boys and girls during puberty. Chronobiol. Int. 2007, 24:969-990.
18. Ferrari E., Gravello L., Muzzoni B., Casarotti D., Paltro M., Solerte S.B., Fioravanti M., Cuzzoni G., Pontiggia B., Magri F. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur. J. Endocrinol. 2001, 144:319-329.
19. Gupta D., Morley J.E. Hypothalamic-pituitary-adrenal (HPA) axis and aging. Compr. Physiol. 2014, 4:1495-1510.
20. Heaney J.L.J., Phillips A.C., Carroll D. Aging, health behaviors, and the diurnal rhythm and awakening response of salivary cortisol. Exp. Aging Res. 2012, 38:295-314.
21. Del Ponte A., Di Monte M.G., Graziani D., Guagnano M.T., Menduni P., Vitullo F., Sensi S. Changes in plasma DHEAS circadian rhythm in elderly men. Prog. Clin. Biol. Res. 1990, 341A:791-796.
22. Kumari M., Badrick E., Sacker A., Kirschbaum C., Marmot M., Chandola T. Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology 2010, 35:1091-1099.
23. Tenover J.S., Matsumoto A.M., Clifton D.K., Bremner W.J. Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men. J. Gerontol. 1988, 43:M163-M169.
24. Adan A., Archer S.N., Hidalgo M.P., Di Milia L., Natale V., Randler C. Circadian typology: a comprehensive review. Chronobiol. Int. 2012, 29:1153-1175.
25. Gröschl M. The physiological role of hormones in saliva. Bioassays 2009, 31:843-852.
26. Baillot A., Vibarel-Rebot N., Thomasson R., Jollin L., Amiot V., Emy P., Collomp K. Serum and saliva adrenocortical hormones in obese diabetic men during submaximal exercise. Horm. Metab. Res. 2011, 43:148-150.
27. Cadore E.L., Lhullier F.L.R., Arias Brentano M., Marczwski Da Silva E., Bueno Ambrosini M., Spinelli R., Ferrari Silva R., Martins Kruel L.F. Salivary hormonal responses to resistance exercise in trained and untrained middle-aged men. J. Sports Med. Phys. Fit. 2009, 49:301-307.
28. Paccotti P., Minetto M., Terzolo M., Ventura M., Ganzit G.P., Borrione P., Termine A., Angeli A. Effects of high-intensity isokinetic exercise on salivary cortisol in athletes with different training schedules: relationships to serum cortisol and lactate. Int. J. Sports Med. 2005, 26:747-755.
29. Port K. Serum and saliva cortisol responses and blood lactate accumulation during incremental exercise testing. Int. J. Sports Med. 1991, 12:490-494.
30. Selye H. Stress and the general adaptation syndrome. Br. Med. J. 1950, 1:1383-1392.
31. Simeoni S., Biselli R., D'Amelio R., Rocca B., Lattanzio S., Mucci L., Davì G., Patacchioli F.R. Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. Stress 2011, 14:282-289.
32. Wetherell M.A., Lovell B., Smith M.A. The effects of an anticipated challenge on diurnal cortisol secretion. Stress 2015, 18:42-48.
33. Kirschbaum C., Pirke K.M., Hellhammer D.H. The "Trier Social Stress Test"-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
34. Hulme P.A., French J.A., Agrawal S. Changes in diurnal salivary cortisol levels in response to an acute stressor in healthy young adults. J. Am. Psychiatr. Nurses Assoc. 2011, 17:339-349.
35. Mommersteeg P.M.C., Heijnen C.J., Verbraak M.J.P.M., van Doornen L.J.P. Clinical burnout is not reflected in the cortisol awakening response, the day-curve or the response to a low-dose dexamethasone suppression test. Psychoneuroendocrinology 2006, 31:216-225.
36. Duan H., Yuan Y., Zhang L., Qin S., Zhang K., Buchanan T.W., Wu J. Chronic stress exposure decreases the cortisol awakening response in healthy young men. Stress 2013, 16:630-637.
37. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int. J. Psychophysiol. 2009, 72:67-73.
38. Gunnar M.R., Vazquez D.M. Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev. Psychopathol. 2001, 13:515-538.
39. Schlotz W., Hellhammer J., Schulz P., Stone A.A. Perceived work overload and chronic worrying predict weekend-weekday differences in the cortisol awakening response. Psychosom. Med. 2004, 66:207-214.
40. Yamaguti S.T.F., de Mendonça A.R.B., Coelho D., Machado A.L., de Souza-Talarico J.N. Atypical secretion of cortisol in nursing professionals. Rev. Esc. Enferm. USP 2015, 49:109-116.
41. Wüst S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25:707-720.
42. Pruessner J.C., Hellhammer D.H., Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom. Med. 1999, 61:197-204.
43. Koss K.J., Mliner S.B., Donzella B., Gunnar M.R. Early adversity, hypocortisolism, and behavior problems at school entry: a study of internationally adopted children. Psychoneuroendocrinology 2015, 66:31-38.
44. Bernton E., Hoover D., Galloway R., Popp K. Adaptation to chronic stress in military trainees. Adrenal androgens, testosterone, glucocorticoids, IGF-1, and immune function. Ann. N. Y. Acad. Sci. 1995, 774:217-231.
45. Follenius M., Brandenberger G., Hietter B. Diurnal cortisol peaks and their relationships to meals. J. Clin. Endocrinol. Metab. 1982, 55:757-761.
46. Rácz B., Dušková M., Jandíková H., Hill M., Vondra K., Stárka L. How does energy intake influence the levels of certain steroids?. Prague Med. Rep. 2015, 116:290-302.
47. Bandín C., Scheer F.a.J.L., Luque A.J., Ávila-Gandía V., Zamora S., Madrid J.A., Gómez-Abellán P., Garaulet M. Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: a randomized, crossover trial. Int. J. Obes. 2015, 39:828-833.
48. Witbracht M., Keim N.L., Forester S., Widaman A., Laugero K. Female breakfast skippers display a disrupted cortisol rhythm and elevated blood pressure. Physiol. Behav. 2015, 140:215-221.
49. Lehtihet M., Arver S., Bartuseviciene I., Pousette A. S-testosterone decrease after a mixed meal in healthy men independent of SHBG and gonadotrophin levels. Andrologia 2012, 44:405-410.
50. Hackney A.C., Lane A.R. Exercise and the regulation of endocrine hormones. Prog. Mol. Biol. Transl. Sci. 2015, 135:293-311.
51. Kraemer W.J., Fry A.C., Warren B.J., Stone M.H., Fleck S.J., Kearney J.T., Conroy B.P., Maresh C.M., Weseman C.A., Triplett N.T. Acute hormonal responses in elite junior weightlifters. Int. J. Sports Med. 1992, 13:103-109.
52. Kraemer W.J., Gordon S.E., Fleck S.J., Marchitelli L.J., Mello R., Dziados J.E., Friedl K., Harman E., Maresh C., Fry A.C. Endogenous anabolic hormonal and growth factor responses to heavy resistance exercise in males and females. Int. J. Sports Med. 1991, 12:228-235.
53. Passelergue P., Lac G. Saliva cortisol, testosterone and T/C ratio variations during a wrestling competition and during the post-competitive recovery period. Int. J. Sports Med. 1999, 20:109-113.
54. Chatard J.C., Atlaoui D., Lac G., Duclos M., Hooper S., Mackinnon L. Cortisol, DHEA, performance and training in elite swimmers. Int. J. Sports Med. 2002, 23:510-515.
55. Teo W., McGuigan M.R., Newton M.J. The effects of circadian rhythmicity of salivary cortisol and testosterone on maximal isometric force, maximal dynamic force, and power output. J. Strength Cond. Res. 2011, 25:1538-1545.
56. Papacosta E., Gleeson M., Nassis G.P. Salivary hormones, IgA, and performance during intense training and tapering in judo athletes. J. Strength Cond. Res. 2013, 27:2569-2580.
57. Filaire E., Ferreira J.P., Oliveira M., Massart A. Diurnal patterns of salivary alpha-amylase and cortisol secretion in female adolescent tennis players after 16 weeks of training. Psychoneuroendocrinology 2013, 38:1122-1132.
58. Minetto M.A., Lanfranco F., Tibaudi A., Baldi M., Termine A., Ghigo E. Changes in awakening cortisol response and midnight salivary cortisol are sensitive markers of strenuous training-induced fatigue. Endocrinol. Invest. 2008, 31:16-24.
59. Georgopoulos N.A., Rottstein L., Tsekouras A., Theodoropoulou A., Koukkou E., Mylonas P., Polykarpou G., Lampropoulou E., Iconomou G., Leglise M., Vagenakis A.G., Markou K.B. Abolished circadian rhythm of salivary cortisol in elite artistic gymnasts. Steroids 2011, 76:353-357.
60. Le Panse B., Vibarel-Rebot N., Parage G., Albrings D., Amiot V., De Ceaurriz J., Collomp K. Cortisol, DHEA, and testosterone concentrations in saliva in response to an international powerlifting competition. Stress 2010, 13:528-532.
61. Rickenlund A., Thorén M., Carlström K., von Schoultz B., Hirschberg A.L. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J. Clin. Endocrinol. Metab. 2004, 89:702-707.
62. Aldred S., Rohalu M., Edwards K., Burns V. Altered DHEA and DHEAS response to exercise in healthy older adults. J. Aging Phys. Act. 2009, 17:77-88.
63. Häkkinen K., Pakarinen A., Kraemer W.J., Newton R.U., Alen M. Basal concentrations and acute responses of serum hormones and strength development during heavy resistance training in middle-aged and elderly men and women. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55:B95-105.
64. Ennour-Idrissi K., Maunsell E., Diorio C. Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Res. 2015, 17:139.
65. Sato K., Iemitsu M., Katayama K., Ishida K., Kanao Y., Saito M. Responses of sex steroid hormones to different intensities of exercise in endurance athletes. Exp. Physiol. 2016, 101:168-175.
66. Shariat A., Kargarfard M., Danaee M., Bahri S., Tamrin M. Intensive resistance exercise and circadian salivary testosterone concentrations among young male recreational lifters. J. Strength Cond. Res. 2015, 29:151-158.
67. Sedliak M., Finni T., Cheng S., Kraemer W.J., Häkkinen K. Effect of time-of-day-specific strength training on serum hormone concentrations and isometric strength in men. Chronobiol. Int. 2007, 24:1159-1177.
68. Cook C.J., Kilduff L.P., Crewther B.T., Beaven M., West D.J. Morning based strength training improves afternoon physical performance in rugby union players. J. Sci. Med. Sport 2014, 17:317-321.
69. Bosco C., Tihanyi J., Viru A. Relationships between field fitness test and basal serum testosterone and cortisol levels in soccer players. Clin. Physiol. 1996, 16:317-322.
70. Crewther B.T., Lowe T., Weatherby R.P., Gill N., Keogh J. Neuromuscular performance of elite rugby union players and relationships with salivary hormones. J. Strength Cond. Res. 2009, 23:2046-2053.
71. Jürimäe J., Jürimäe T., Purge P. Plasma testosterone and cortisol responses to prolonged sculling in male competitive rowers. J. Sports Sci. 2001, 19:893-898.
72. Le Panse B., Labsy Z., Baillot A., Vibarel-Rebot N., Parage G., Albrings D., Lasne F., Collomp K. Changes in steroid hormones during an international powerlifting competition. Steroids 2012, 77:1339-1344.
73. Snegovskaya V., Viru A. Elevation of cortisol and growth hormone levels in the course of further improvement of performance capacity in trained rowers. Int. J. Sports Med. 1993, 14:202-206.
74. Aguirre L.E., Jan I.Z., Fowler K., Waters D.L., Villareal D.T., Armamento-Villareal R. Testosterone and adipokines are determinants of physical performance, strength, and aerobic fitness in frail. Int. J. Endocrinol. 2014, 2014:507395.
75. Hayes L.D., Bickerstaff G.F., Baker J.S. Interactions of cortisol, testosterone, and resistance training: influence of circadian rhythms. Chronobiol. Int. 2010, 27:675-705.
76. Hatfield D.L., Nicoll J.X., Kraemer W.J. Effects of circadian rhythm on power, force, and hormonal response in young men. J. Strength. Cond. Res. 2016, 30(3):725-732.
77. Spiegel R.J., Vigersky R.A., Oliff A.I., Echelberger C.K., Bruton J., Poplack D.G. Adrenal suppression after short-term corticosteroid therapy. Lancet 1979, 24:630-633.
78. Carella M.J., Srivastava L.S., Gossain V.V., Rovner D.R. Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy. J. Clin. Endocrinol. Metab. 1993, 76:1188-1191.
79. Habib G., Artul S., Chernin M., Hakim G., Jabbour A. The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate at the knee joint on the hypothalamic-pituitary-adrenal axis: a case-controlled study. J. Investig. Med. 2013, 61:1104-1107.
80. Streck W.F., Lockwood D.H. Pituitary adrenal recovery following short-term suppression with corticosteroid. Am. J. Med. 1979, 66:910-914.
81. Watson A.C., Rosenfield R.L., Fang V.S. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin. Endocrinol. 1988, 28:471-477.
82. Yang T.-T., Hsiao F.-H., Wang K.-C., Ng S.-M., Ho R.T.H., Chan C.L.W., Lai Y.-M., Chen Y.-T. The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder. J. Nerv. Ment. Dis. 2009, 197:401-406.
83. Harmer C.J., Bhagwagar Z., Shelley N., Cowen P.J. Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology 2003, 167:112-114.
84. Manthey L., Leeds C., Giltay E.J., van Veen T., Vreeburg S.A., Penninx B.W.J.H., Zitman F.G. Antidepressant use and salivary cortisol in depressive and anxiety disorders. Eur. Neuropsychopharmacol. 2011, 21:691-699.
85. Giltay E.J., Enter D., Zitman F.G., Penninx B.W.J.H., van Pelt J., Spinhoven P., Roelofs K. Salivary testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. J. Psychosom. Res. 2012, 72:205-213.
86. Boisseau, Enea C., Diaz V., Dugué B., Corcuff J.B., Duclos M. Oral contraception but not menstrual cycle phase is associated with increased free cortisol levels and low hypothalamo-pituitary-adrenal axis reactivity. J. Endocrinol. Investig. 2013, 36:955-964.
87. Carlström K., Karlsson R., Von Schoultz B. Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand. J. Clin. Lab. Invest. 2002, 62:361-368.
88. Pluchino N., Cubeddu A., Begliuomini S., Merlini S., Giannini A., Bucci F., Casarosa E., Luisi M., Cela V., Genazzani A.R. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum. Reprod. 2009, 24:2303-2309.
89. Winkler U.H., Sudik R. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters. Contraception 2009, 79:15-23.
90. Bouma E.M.C., Riese H., Ormel J., Verhulst F.C., Oldehinkel A.J. Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study. Psychoneuroendocrinology 2009, 34:884-893.
91. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997, 61:2539-2549.
92. Wüst S., Wolf J., Hellhammer D.H., Federenko I., Schommer N., Kirschbaum C. The cortisol awakening response - normal values and confounds. Noise Health 2000, 2:79-88.
93. Adinoff B., Iranmanesh A., Veldhuis J., Fisher L. Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res. World 1998, 22:67-72.
94. Adinoff B., Ruether K., Krebaum S., Iranmanesh A., Williams M.J. Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol. Clin. Exp. Res. 2003, 27:1420-1427.
95. Evans B.E., Greaves-Lord K., Euser A.S., Franken I.H.A., Huizink A.C. The relation between hypothalamic-pituitary-adrenal (HPA) axis activity and age of onset of alcohol use. Addiction 2012, 107:312-322.
96. Ritter P.S., Höfler M., Wittchen H.U., Lieb R., Bauer R.M., Pfennig M.A., Beesdo-Baum K. Disturbed sleep as risk factor for the subsequent onset of bipolar disorder-Data from a 10-year prospective-longitudinal study among adolescents and young adults. J. Psychiatr. Res. 2015, 68:76-82.
97. Badrick E., Bobak M., Britton A., Kirschbaum C., Marmot M., Kumari M. The relationship between alcohol consumption and cortisol secretion in an aging cohort. Clin. Endocrinol. Metab. 2008, 93:750-757.
98. Mukai M., Uchimura N., Hirano T., Ohshima H., Ohshima M., Nakamura J. Circadian rhythms of hormone concentrations in alcohol withdrawal. Psychiatry Clin. Neurosci. 1998, 52:238-240.
99. Iranmanesh A., Veldhuis J.D., Johnson M.L., Lizarralde G. 24-hour pulsatile and circadian patterns of cortisol secretion in alcoholic men. J. Androl. 1989, 10:54-63.
100. Venkat K.K., Arora M.M., Singh P., Desai M., Khatkhatay I. Effect of alcohol consumption on bone mineral density and hormonal parameters in physically active male soldiers. Bone 2009, 45:449-454.
101. Gavrieli A., Yannakoulia M., Fragopoulou E., Margaritopoulos D., Chamberland J.P., Kaisari P., Kavouras S.A., Mantzoros C.S. Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men. J. Nutr. 2011, 141:703-707.
102. Rieth N., Vibarel-Rebot N., Buisson C., Jaffré C., Collomp K. Caffeine and saliva steroids in young healthy recreationally trained women: impact of regular caffeine intake. Endocrine 2016, 52:391-394.
103. Lovallo W.R., Whitsett T.L., al'Absi M., Sung B.H., Vincent A.S., Wilson M.F. Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels. Psychosom. Med. 2005, 67:734-739.
104. MacKenzie T., Comi R., Sluss P., Keisari R., Manwar S., Kim J., Larson R., Baron J.A. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metab. Clin. Exp. 2007, 56:1694-1698.
105. Wedick N.M., Mantzoros C.S., Ding E.L., Brennan A.M., Rosner B., Rimm E.B., Hu F.B., van Dam R.M. The effects of caffeinated and decaffeinated coffee on sex hormone-binding globulin and endogenous sex hormone levels: a randomized controlled trial. Nutr. J. 2012, 11:86.
106. Lovallo W.R., Farag N.H., Vincent A.S., Thomas T.L., Wilson M.F. Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women. Pharmacol. Biochem. Behav. 2006, 83:441-447.
107. Manthey L., Giltay E.J., van Veen T., Neven A.K., Vreeburg S.A., Penninx B.W.J.H., Zitman F.G. Long-term benzodiazepine use and salivary cortisol: the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychopharmacol. 2010, 30:160-168.
108. Crippa J.A., Zuardi A.W., Hallak J.E. Therapeutical use of the cannabinoids in psychiatry. Rev. Bras. Psiquiatr. 2010, 32(Suppl. 1):S56-S66.
109. Cone E.J., Johnson R.E., Moore J.D., Roache J.D. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol. Biochem. Behav. 1986, 24:1749-1754.
110. Ranganathan M., Braley G., Pittman B., Cooper T., Perry E., Krystal J., D'Souza D.C. The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology 2009, 203:737-744.
111. Somaini L., Manfredini M., Amore M., Zaimovic A., Raggi M.A., Leonardi C., Gerra M.L., Donnini C., Gerra G. Psychobiological responses to unpleasant emotions in cannabis users. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262:47-57.
112. van Leeuwen A.P., Creemers H.E., Greaves-Lord K., Verhulst F.C., Ormel J., Huizink A.C. Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: the TRAILS study. Addiction 2011, 106:1484-1492.
113. Huizink A.C., Ferdinand R.F., Ormel J., Verhulst F.C. Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction 2006, 101:1581-1588.
114. Monteleone P., Di Filippo C., Fabrazzo M., Milano W., Martiadis V., Corrivetti G., Monteleone A.M., Maj M. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. Psychiatry Res. 2014, 215:263-267.
115. Parrott A.C., Montgomery C., Wetherell M.A., Downey L.A., Stough C., Scholey A.B. MDMA, cortisol, and heightened stress in recreational ecstasy users. Behav. Pharmacol. 2014, 25:458-472.
116. Wetherell M.A., Montgomery C. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users. Psychopharmacology 2014, 231:1365-1375.
117. al'Absi M., Khalil N.S., Al Habori M., Hoffman R., Fujiwara K., Wittmers L. Effects of chronic khat use on cardiovascular, adrenocortical, and psychological responses to stress in men and women. Am. J. Addict. 2013, 22:99-107.
118. Olsson E.M., von Schéele B., Panossian A.G. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009, 75:105-112.
119. Vgontzas A.N., Chrousos G.P. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol. Metab. Clin. N. Am. 2002, 31:15-36.
120. Balbo M., Leproult R., Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int. J. Endocrinol. 2010, 2010:759234.
121. Pejovic S., Basta M., Vgontzas A.N., Kritikou I., Shaffer M.L., Tsaoussoglou M., Stiffler D., Stefanakis Z., Bixler E.O., Chrousos G.P. Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E890-E896.
122. Voderholzer U., Piosczyk H., Holz J., Feige B., Loessl B., Kopasz M., Riemann D., Nissen C. The impact of increasing sleep restriction on cortisol and daytime sleepiness in adolescents. Neurosci. Lett. 2012, 507:161-166.
123. Guyon A., Balbo M., Morselli L.L., Tasali E., Leproult R., L'Hermite-Balériaux M., Van Cauter E., Spiegel K. Adverse effects of two nights of sleep restriction on the hypothalamic-pituitary-adrenal axis in healthy men. J. Clin. Endocrinol. Metab. 2014, 99:2861-2868.
124. Leproult R., Copinschi G., Buxton O., Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997, 20:865-870.
125. Nedeltcheva A.V., Kessler L., Imperial J., Penev P.D. Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J. Clin. Endocrinol. Metab. 2009, 94:3242-3250.
126. Reynolds A.C., Dorrian J., Liu P.Y., Van Dongen H.P.A., Wittert G.A., Harmer L.J., Banks S. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS One 2012, 7:e41218.
127. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
128. Spiegel K., Leproult R., L'hermite-Balériaux M., Copinschi G., Penev P.D., Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J. Clin. Endocrinol. Metab. 2004, 89:5762-5771.
129. Carev M., Karanović N., Bagatin J., Matulić N.B., Pecotić R., Valić M., Marinović-Terzić I., Karanović S., Dogas Z. Blood pressure dipping and salivary cortisol as markers of fatigue and sleep deprivation in staff anesthesiologists. Coll. Anthropol. 2011, 35(Suppl. 1):133-138.
130. Chapotot F., Buguet A., Gronfier C., Brandenberger G. Hypothalamo-pituitary-adrenal axis activity is related to the level of central arousal: effect of sleep deprivation on the association of high-frequency waking electroencephalogram with cortisol release. Neuroendocrinology 2001, 73:312-321.
131. von Treuer K., Norman T.R., Armstrong S.M. Overnight human plasma melatonin, cortisol, prolactin, TSH, under conditions of normal sleep, sleep deprivation, and sleep recovery. J. Pineal Res. 1996, 20:7-14.
132. Weitzman E.D., Zimmerman J.C., Czeisler C.A., Ronda J. Cortisol secretion is inhibited during sleep in normal man. J. Clin. Endocrinol. Metab. 1983, 56:352-358.
133. Vgontzas A.N., Mastorakos G., Bixler E.O., Kales A., Gold P.W., Chrousos G.P. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin. Endocrinol. 1999, 51:205-215.
134. Wu H., Zhao Z., Stone W.S., Huang L., Zhuang J., He B., Zhang P., Li Y. Effects of sleep restriction periods on serum cortisol levels in healthy men. Brain Res. Bull. 2008, 77:241-245.
135. Leproult R., Van Cauter E. Role of sleep and sleep loss in hormonal release and metabolism. Endocr. Dev. 2010, 17:11-21.
136. Omisade A., Buxton O.M., Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol. Behav. 2010, 99:651-656.
137. LeRoux A., Wright L., Perrot T., Rusak B. Impact of menstrual cycle phase on endocrine effects of partial sleep restriction in healthy women. Psychoneuroendocrinology 2014, 49:34-46.
138. Leproult R., Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 2011, 305:2173-2174.
139. Schmid S.M., Hallschmid M., Jauch-Chara K., Lehnert H., Schultes B. Sleep timing may modulate the effect of sleep loss on testosterone. Clin. Endocrinol. 2012, 77:749-754.
140. Lemmer B., Kern R.-I., Nold G., Lohrer H. Jet lag in athletes after eastward and westward time-zone transition. Chronobiol. Int. 2002, 19:743-764.
141. Loat C.E., Rhodes E.C. Jet-lag and human performance. Sports Med. 1989, 8:226-238.
142. Samuels C.H. Jet lag and travel fatigue: a comprehensive management plan for sport medicine physicians and high-performance support teams. Clin. J. Sport Med. 2012, 22:268-273.
143. Rutters F., Lemmens S.G., Adam T.C., Bremmer M.A., Elders P.J., Nijpels G., Dekker J.M. Is social jetlag associated with an adverse endocrine, behavioral, and cardiovascular risk profile?. J. Biol. Rhythm. 2014, 29:377-383.
144. Bostock S., Steptoe A. Influences of early shift work on the diurnal cortisol rhythm, mood and sleep: within-subject variation in male airline pilots. Psychoneuroendocrinology 2013, 38:533-541.
145. Bullock N., Martin D.T., Ross A., Rosemond D., Marino F.E. Effect of long haul travel on maximal sprint performance and diurnal variations in elite skeleton athletes. Br. J. Sports Med. 2007, 41:569-573.
146. Doane L.D., Kremen W.S., Eaves L.J., Eisen S.A., Hauger R., Hellhammer D., Levine S., Lupien S., Lyons M.J., Mendoza S., Prom-Wormley E., Xian H., York T.P., Franz C.E., Jacobson K.C. Associations between jet lag and cortisol diurnal rhythms after domestic travel. Health Psychol. 2010, 29:117-123.
147. Piérard C., Beaumont M., Enslen M., Chauffard F., Tan D.X., Reiter R.J., Fontan A., French J., Coste O., Lagarde D. Resynchronization of hormonal rhythms after an eastbound flight in humans: effects of slow-release caffeine and melatonin. Eur. J. Appl. Physiol. 2001, 85:144-150.
148. Caufriez A., Moreno-Reyes R., Leproult R., Vertongen F., Van Cauter E., Copinschi G. Immediate effects of an 8-h advance shift of the rest-activity cycle on 24-h profiles of cortisol. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1147-E1153.
149. Atkinson G., Buckley P., Edwards B., Reilly T., Waterhouse J. Are there hangover-effects on physical performance when melatonin is ingested by athletes before nocturnal sleep?. Int. J. Sports Med. 2001, 22:232-234.
150. Beaumont M., Batéjat D., Piérard C., Van Beers P., Denis J.B., Coste O., Doireau P., Chauffard F., French J., Lagarde D. Caffeine or melatonin effects on sleep and sleepiness after rapid eastward transmeridian travel. J. Appl. Physiol. 2004, 96:50-58.
151. Edwards B.J., Atkinson G., Waterhouse J., Reilly T., Godfrey R., Budgett R. Use of melatonin in recovery from jet-lag following an eastward flight across 10 time-zones. Ergonomics 2000, 43:1501-1513.
152. Lagarde D., Chappuis B., Billaud P.F., Ramont L., Chauffard F., French J. Evaluation of pharmacological aids on physical performance after a transmeridian flight. Med. Sci. Sports Exerc. 2001, 33:628-634.
153. Nedeltcheva A.V., Scheer F.A.J.L. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 2014, 21:293-298.
154. Depner C.M., Stothard E.R., Wright K.P. Metabolic consequences of sleep and circadian disorders. Curr. Diab. Rep. 2014, 14:507.
155. Björntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes. Rev. 2001, 2:73-86.
156. Brotman D.J., Golden S.H., Wittstein I.S. The cardiovascular toll of stress. Lancet 2007, 370:1089.
157. Rosmond R., Dallman M.F., Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998, 83:1853-1859.
158. Rosmond R., Björntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 2000, 247:188-197.
159. Pasquali R., Vicennati V., Cacciari M., Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 2006, 1083:111-128.
160. Incollingo Rodriguez A.C., Epel E.S., White M.L., Standen E.C., Seckl J.R., Tomiyama A.J. Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: a systematic review. Psychoneuroendocrinology 2015, 62:301-318.
161. Walker B.R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 2007, 157:545-559.
162. Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent. Psychopharmacol. 2005, 6:341-347.
163. Copinschi G., Leproult R., Spiegel K. The important role of sleep in metabolism. Front. Horm. Res. 2014, 42:59-72.
164. Ljung T., Andersson B., Bengtsson B., Björntorp P., Mårin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes. Res. 1996, 4:277-282.
165. Champaneri S., Xu X., Carnethon M.R., Bertoni A.G., Seeman T., DeSantis A.S., Diez Roux A., Shrager S., Golden S.H. Diurnal salivary cortisol is associated with body mass index and waist circumference: the Multiethnic Study of Atherosclerosis. Obesity (Silver Spring) 2013, 21:E56-E63.
166. Wallerius S., Rosmond R., Ljung T., Holm G., Björntorp P. Rise in morning saliva cortisol is associated with abdominal obesity in men: a preliminary report. J. Endocrinol. Investig. 2003, 26:616-619.
167. Steptoe A., Kunz-Ebrecht S.R., Brydon L., Wardle J. Central adiposity and cortisol responses to waking in middle-aged men and women. Int. J. Obes. Relat. Metab. Disord. 2004, 28:1168-1173.
168. Filipovsky J., Ducimetiére P., Eschwége E., Richard J.L., Rosselin G., Claude J.R. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J. Hypertens. 1996, 14:229-235.
169. Kumari M., Chandola T., Brunner E., Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in theWhitehall II study. J. Clin. Endocrinol. Metab. 2010, 95:4415-4423.
170. Tchernof A., Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur. J. Endocrinol. 2004, 151:1-14.
171. Kaplan S.A., Meehan A.G., Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?. J. Urol. 2006, 176:1524-1527.
172. Diaz-Arjonilla M., Schwarcz M., Swerdloff R.S., Wang C. Obesity, low testosterone levels and erectile dysfunction. Int. J. Impot. Res. 2009, 21:89-98.
173. Cáp J. Androgen deficit and diabetes. Vnitr. Lek. 2012, 58:228-231.
174. Gettler L.T., McDade T.W., Feranil A.B., Agustin S.S., Kuzawa C.W. Salivary estradiol and testosterone in Filipino men: diurnal patterns and relationships with adiposity. Am. J. Hum. Biol. 2014, 26:376-383.
175. Hackett R.A., Steptoe A., Kumari M. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J. Clin. Endocrinol. Metab. 2014, 99:4625-4631.
176. Lederbogen F., Hummel J., Fademrecht C., Krumm B., Kühner C., Deuschle M., Ladwig K.-H., Meisinger C., Wichmann H.-E., Lutz H., Breivogel B. Flattened circadian cortisol rhythm in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2011, 119:573-575.
177. Liu H., Bravata D.M., Cabaccan J., Raff H., Ryzen E. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin. Endocrinol. 2005, 63:642-649.
178. Vreeburg S.A., Kruijtzer B.P., van Pelt J., van Dyck R., DeRijk R.H., Hoogendijk W.J.G., Smit J.H., Zitman F.G., Penninx B.W.J.H. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 2009, 34:1109-1120.
179. Bruehl H., Wolf O.T., Convit A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 2009, 34:815-821.
180. Champaneri S., Xu X., Carnethon M.R., Bertoni A.G., Seeman T., Diez Roux A., Golden S.H. Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metab. Clin. Exp. 2012, 61:986-995.
181. Wirtz P.H., von Känel R., Emini L., Ruedisueli K., Groessbauer S., Maercker A., Ehlert U. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: blunted cortisol response to awakening and lower negative feedback sensitivity. Psychoneuroendocrinology 2007, 32:430-436.
182. Whitworth J.A., Gordon D., McLachlan-Troup N., Scoggins B.A., Moulds R.W. Dexamethasone suppression in essential hypertension: effects on cortisol and blood pressure. Clin. Exp. Hypertens. A 1989, 11:323-335.
183. Wirtz P.H., von Känel R., Frey K., Ehlert U., Fischer J.E. Glucocorticoid sensitivity of circulating monocytes in essential hypertension. Am. J. Hypertens. 2004, 17:489-494.
184. Walker B.R. Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. Endocr. Res. 1996, 22:701-708.
185. Soro A., Ingram M.C., Tonolo G., Glorioso N., Fraser R. Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension. Hypertension 1995, 25:67-70.
186. Kidambi S., Kotchen J.M., Grim C.E., Raff H., Mao J., Singh R.J., Kotchen T.A. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007, 49:704-711.
187. Troxler R.G., Sprague E.A., Albanese R.A., Fuchs R., Thompson A.J. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 1977, 26:151-162.
188. Kumari M., Shipley M., Stafford M., Kivimaki M. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J. Clin. Endocrinol. Metab. 2011, 96:1478-1485.
189. Vogelzangs N., Beekman A.T.F., Milaneschi Y., Bandinelli S., Ferrucci L., Penninx B.W.J.H. Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J. Clin. Endocrinol. Metab. 2010, 95:4959-4964.
190. Hajat A., Diez-Roux A.V., Sánchez B.N., Holvoet P., Lima J.A., Merkin S.S., Polak J.F., Seeman T.E., Wu M. Examining the association between salivary cortisol levels and subclinical measures of atherosclerosis: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 2013, 38:1036-1046.
191. Matthews K., Schwartz J., Cohen S., Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom. Med. 2006, 68:657-661.
192. Dekker M.J.H.J., Koper J.W., van Aken M.O., Pols H.a.P., Hofman A., de Jong F.H., Kirschbaum C., Witteman J.C.M., Lamberts S.W.J., Tiemeier H. Salivary cortisol is related to atherosclerosis of carotid arteries. J. Clin. Endocrinol. Metab. 2008, 93:3741-3747.
193. Hamer M., Endrighi R., Venuraju S.M., Lahiri A., Steptoe A. Cortisol responses to mental stress and the progression of coronary artery calcification in healthy men and women. PLoS One 2012, 7:e31356.
194. Eller N.H., Netterstrøm B., Allerup P. Progression in intima media thickness-the significance of hormonal biomarkers of chronic stress. Psychoneuroendocrinology 2005, 30:715-723.
195. Hurwitz Eller N., Netterstrøm B., Hansen A.M. Cortisol in urine and saliva: relations to the intima media thickness, IMT. Atherosclerosis 2001, 159:175-185.
196. O'Neill S., O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 2015, 16:1-12.
197. Johnson L.W., Weinstock R.S. The metabolic syndrome: concepts and controversy. Mayo Clin. Proc. 2006, 81:1615-1620.
198. Abraham S.B., Rubino D., Sinaii N., Ramsey S., Nieman L.K. Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity (Silver Spring) 2013, 21:E105-E117.
199. Lasikiewicz N., Hendrickx H., Talbot D., Dye L. Exploration of basal diurnal salivary cortisol profiles in middle-aged adults: associations with sleep quality and metabolic parameters. Psychoneuroendocrinology 2008, 33:143-151.
200. Kajantie E., Eriksson J., Osmond C., Wood P.J., Forsén T., Barker D.J.P., Phillips D.I.W. Size at birth, the metabolic syndrome and 24-h salivary cortisol profile. Clin. Endocrinol. 2004, 60:201-207.
201. Bengtsson I., Lissner L., Ljung T., Rosengren A., Thelle D., Währborg P. The cortisol awakening response and the metabolic syndrome in a population-based sample of middle-aged men and women. Metab. Clin. Exp. 2010, 59:1012-1019.
202. Kuehl L.K., Hinkelmann K., Muhtz C., Dettenborn L., Wingenfeld K., Spitzer C., Kirschbaum C., Wiedemann K., Otte C. Hair cortisol and cortisol awakening response are associated with criteria of the metabolic syndrome in opposite directions. Psychoneuroendocrinology 2015, 51:365-370.
203. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
204. Murphy B.E. Steroids and depression. J. Steroid. Biochem. Mol. Biol. 1991, 38:537-559.
205. Holsboer F. Corticotropin-releasing hormone modulators and depression. Curr. Opin. Investig. Drugs 2003, 4:46-50.
206. Meerlo P., Sgoifo A., Turek F.W. The effects of social defeat and other stressors on the expression of circadian rhythms. Stress 2002, 5:15-22.
207. Vammen M.A., Mikkelsen S., Hansen A.M., Gryderup M.B., Andersen J.H., Bonde J.P., Buttenschon H.N., Kolstad H.A., Kaergaard A., Kaerlev L., Mors O., Rugulies R., Thomsen J.F. Salivary cortisol and depression in public sector employees:cross-sectional and short term follow-up findings. Psychoneuroendocrinology 2014, 41:63-74.
208. Goodyer I.M. Physical symptoms and depressive disorders in childhood and adolescence. J. Psychosom. Res. 1996, 41:405-408.
209. Goodyer I.M., Herbert J., Tamplin A., Altham P.M. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br. J. Psychiatry 2000, 177:499-504.
210. Dedovic K., Engert V., Duchesne A., Lue S.D., Andrews J., Efanov S.I., Beaudry T., Pruessner J.C. Cortisol awakening response and hippocampal volume: vulnerability for major depressive disorder?. Biol. Psychiatry 2010, 68:847-853.
211. Giese-Davis J., Wilhelm F.H., Conrad A., Abercrombie H.C., Sephton S., Yutsis M., Neri E., Taylor C.B., Kraemer H.C., Spiegel D. Depression and stress reactivity in metastatic breast cancer. Psychosom. Med. 2006, 68:675-683.
212. Huber T.J., Issa K., Schik G., Wolf O.T. The cortisol awakening response is blunted in psychotherapy inpatients suffering from depression. Psychoneuroendocrinology 2006, 31:900-904.
213. Saban K.L., Mathews H.L., Bryant F.B., O'Brien T.E., Janusek L.W. Depressive symptoms and diurnal salivary cortisol patterns among female caregivers of stroke survivors. Biol. Res. Nurs. 2012, 14:396-404.
214. Jabben N., Nolen W.A., Smit J.H., Vreeburg S.A., Beekman A.T., Penninx B.W. Co-occurring manic symptomatology influences HPA axis alterations in depression. J. Psychiatr. Res. 2011, 45:1208-1213.
215. Vrshek-Schallhorn S., Doane L.D., Mineka S., Zinbarg R.E., Craske M.G., Adam E.K. The cortisol awakening response predicts major depression: predictive stability over a 4-year follow-up and effect of depression history. Psychol. Med. 2013, 43:483-493.
216. Abercrombie H.C., Giese-Davis J., Sephton S., Epel E.S., Turner-Cobb J.M., Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004, 29:1082-1092.
217. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 2000, 92:994-1000.
218. Spiegel D., Giese-Davis J., Taylor C.B., Kraemer H. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 2006, 31:1231-1244.
219. Scheyer K., Urizar G.G. Altered stress patterns and increased risk for postpartum depression among low-income pregnant women. Arch. Womens Ment. Health 2016, 19:317-328.
220. Jones B.D., Chopra K.K., Grummitt J., Ravindran A., Matthews S.G., Levitan R.D. High reactivity of the cortisol awakening response predicts positive treatment outcome in heterogeneous depressed patients completing an alternate milieu inpatient program. Gen. Hosp. Psychiatry 2015, 37:601-605.
221. Adam E.K., Doane L.D., Zinbarg R.E., Mineka S., Craske M.G., Griffith J.W. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology 2010, 35:921-931.
222. Keller J., Flores B., Gomez R.G., Solvason H.B., Kenna H., Williams G.H., Schatzberg A.F. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry 2006, 60:275-281.
223. Wessa M., Rohleder N., Kirschbaum C., Flor H. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 2006, 31:209-215.
224. Wahbeh H., Oken B.S. Salivary cortisol lower in posttraumatic stress disorder. J. Trauma. Stress. 2013, 26:241-248.
225. Freidenberg B.M., Gusmano R., Hickling E.J.E.J., Blanchard E.B., Bremner J.D., Fry C. Women with PTSD have lower basal salivary cortisol levels later in the day than do men with PTSD: a preliminary study. Physiol. Behav. 2010, 99:234-236.
226. Harris A., Reme S.E., Tangen T., Hansen A.M., Garde A.H., Eriksen H.R. Diurnal cortisol rhythm: associated with anxiety and depression, or just an indication of lack of energy?. Psychiatry Res. 2015, 228:209-215.
227. Lo Sauro C., Ravaldi C., Cabras P.L., Faravelli C., Ricca V. Stress, hypothalamic-pituitary-adrenal axis and eating disorders. Neuropsychobiology 2008, 57:95-115.
228. Frankel R.J., Jenkins J.S. Hypothalamic-pituitary function in anorexia nervosa. Acta Endocrinol. 1975, 78:209-221.
229. Gold P.W., Gwirtsman H., Avgerinos P.C., Nieman L., Gallucci W.T., Kaye W., Jimerson D., Ebert M., Rittmaster R., Loriaux L., Chrousos G. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N. Engl. J. Med. 1986, 314:1335-1342.
230. Putignano P., Dubini A., Toja P., Invitti C., Bonfanti S., Redaelli G., Zappulli D., Cavagnini F. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur. J. Endocrinol. 2001, 145:165-171.
231. Seed J.A., McCue P.M., Wesnes K.A., Dahabra S., Young A.H. Basal activity of the HPA axis and cognitive function in anorexia nervosa. Int. J. Neuropsychopharmacol. 2002, 5:17-25.
232. Sirinathsinghji D.J., Mills I.H. Concentration patterns of plasma dehydroepiandrosterone, delta 5-androstenediol and their sulphates, testosterone and cortisol in normal healthy women and in women with anorexia nervosa. Acta Endocrinol. 1985, 108:255-260.
233. dos Santos E., dos Santos J.E., Ribeiro R.P., Rosa e Silva A.C.J.S., Moreira A.C., de Sá M.F.S. Absence of circadian salivary cortisol rhythm in women with anorexia nervosa. J. Pediatr. Adolesc. Gynecol. 2007, 20:13-18.
234. Monteleone P., Scognamiglio P., Monteleone A.M., Mastromo D., Steardo L., Serino I., Maj M. Abnormal diurnal patterns of salivary α-amylase and cortisol secretion in acute patients with anorexia nervosa. World J. Biol. Psychiatry 2011, 12:455-461.
235. Oskis A., Loveday C., Hucklebridge F., Thorn L., Clow A. Diurnal patterns of salivary cortisol and DHEA in adolescent anorexia nervosa. Stress 2012, 15:601-607.
236. Vierhapper H., Kiss A., Nowotny P., Wiesnagrotzki S., Monder C., Waldhäusl W. Metabolism of cortisol in anorexia nervosa. Acta Endocrinol. 1990, 122:753-758.
237. Yamazaki K., Saito Y., Okada F., Fujieda T., Yamashita I. An application of neuroendocrinological studies in autistic children and Heller's syndrome. J. Autism Child. Schizophr. 1975, 5:323-332.
238. Hill S.D., Wagner E.A., Shedlarski J.G., Sears S.P. Diurnal cortisol and temperature variation of normal and autistic children. Dev. Psychobiol. 1977, 10:579-583.
239. Corbett B.A., Schupp C.W., Levine S., Mendoza S. Comparing cortisol, stress, and sensory sensitivity in children with autism. Autism Res. 2009, 2:39-49.
240. Tordjman S., Anderson G.M., Kermarrec S., Bonnot O., Geoffray M.-M., Brailly-Tabard S., Chaouch A., Colliot I., Trabado S., Bronsard G., Coulon N., Botbol M., Charbuy H., Camus F., Touitou Y. Altered circadian patterns of salivary cortisol in low-functioning children and adolescents with autism. Psychoneuroendocrinology 2014, 50:227-245.
241. Lam K.S.L., Aman M.G., Arnold L.E. Neurochemical correlates of autistic disorder: a review of the literature. Res. Dev. Disabil. 2006, 27:254-289.
242. Taylor J.L., Corbett B.A. A review of rhythm and responsiveness of cortisol in individuals with autism spectrum disorders. Psychoneuroendocrinology 2014, 49:207-228.
243. Zinke K., Fries E., Kliegel M., Kirschbaum C., Dettenborn L. Children with high-functioning autism show a normal cortisol awakening response (CAR). Psychoneuroendocrinology 2010, 35:1578-1582.
244. Corbett B.A., Schupp C.W. The cortisol awakening response (CAR) in male children with autism spectrum disorder. Horm. Behav. 2014, 65:345-350.
245. Marinović-Curin J., Marinović-Terzić I., Bujas-Petković Z., Zekan L., Skrabić V., Dogas Z., Terzić J. Slower cortisol response during ACTH stimulation test in autistic children. Eur. Child Adolesc. Psychiatry 2008, 17:39-43.
246. Majewska M.D., Hill M., Urbanowicz E., Rok-Bujko P., Bieńkowski P., Namysłowska I., Mierzejewski P. Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children. Eur. Child Adolesc. Psychiatry 2014, 23:485-498.
247. El-Baz F., Hamza R.T., Ayad M.S., Mahmoud N.H. Hyperandrogenemia in male autistic children and adolescents: relation to disease severity. Int. J. Adolesc. Med. Health 2014, 26:79-84.
248. Tordjman S., Anderson G.M., McBride P.A., Hertzig M.E., Snow M.E., Hall L.M., Ferrari P., Cohen D.J. Plasma androgens in autism. J. Autism Dev. Disord. 1995, 25:295-304.
249. Bradley A.J., Dinan T.G. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J. Psychopharmacol. 2010, 24:91-118.
250. Ryan M.C.M., Sharifi N., Condren R., Thakore J.H. Evidence of basal pituitary-adrenal over activity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 2004, 29:1065-1070.
251. Gallagher P., Watson S., Smith M.S., Young A.H., Ferrier N. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophr. Res. 2007, 90:258-265.
252. Jansen L.M.C., Gispen-de Wied C.C., Gademan P.J., De Jonge R.C.J., van der Linden J.A., Kahn R.S. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr. Res. 1998, 33:87-94.
253. Gil-Ad I., Dickerman Z., Amdursky S., Laron Z. Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects. Psychopharmacology 1986, 88:496-499.
254. Jiang H.K., Wang J.Y. Diurnal melatonin and cortisol secretion profiles in medicated schizophrenic patients. J. Formos. Med. Assoc. 1998, 97:830-837.
255. Monteleone P., Maj M., Fusco M., Kemali D., Reiter R.J. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr. Res. 1992, 7:77-84.
256. Rao M.L., Strebel B., Halaris A., Gross G., Braunig P., Huber G., Marler M. Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones and cortisol in schizophrenia. Psychiatry Res. 1995, 57:21-39.
257. van Cauter E., Linkowski P., Kerkhofs M., Hubain P., L'Hermite-Balériaux M., Leclercq R., Brasseur M., Copinschi G., Mendlewicz J. Circadian and sleep-related endocrine rhythms in schizophrenia. Arch. Gen. Psychiatry 1991, 48:348-356.
258. Christie J.E., Whalley L.J., Dick H., Blackwood D.H.R., Blackburn I.M., Fink G. Raised plasma cortisol concentration a feature of drug-free psychotics and not specific for depression. Br. J. Psychiatry 1986, 148:58-65.
259. Morphy A.M., Fava G.A., Carson S.W., Perini G.I., Molnar G., Jusko W.J. The metyrapone test in schizophrenic patients and healthy subjects. Neuropsychobiology 1985, 14:35-38.
260. Hempel R.J., Tulen J.H.M., van Beveren N.J.M., Röder C.H., de Jong F.H., Hengeveld M.W. Diurnal cortisol patterns of young male patients with schizophrenia. Psychiatry Clin. Neurosci. 2010, 64:548-554.
261. Harris D.S., Wolkowitz O.M., Reus V.I. Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients. World J. Biol. Psychiatry 2001, 2:99-102.
262. Tourney G., Hatfield L. Plasma androgens in male schizophrenics. Arch. Gen. Psychiatry 1972, 27:753-755.
263. Tourney G., Erb J.L. Temporal variations in androgens and stress hormones in control and schizophrenic subjects. Biol. Psychiatry 1979, 14:395-404.
264. Brophy M.H., Rush A.J., Crowley G. Cortisol, estradiol, and androgens in acutely ill paranoid schizophrenics. Biol. Psychiatry 1983, 18:583-590.
265. Ritsner M., Maayan R., Gibel A., Strous R.D., Modai I., Weisman A. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur. Neuropsychopharmacol. 2004, 14:267-273.
266. Erb J.L., Kadane J.B., Tourney G., Mickelsen R., Trader D., Szabo R., Davis V. Discrimination between schizophrenic and control subjects by means of plasma dehydroepiandrosterone measurements. J. Clin. Endocrinol. Metab. 1981, 52:181-186.
267. Markianos M., Hatzimanolis J., Lykouras L. Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients. Eur. Neuropsychopharmacol. 1999, 9:533-566.
268. Mason J.W., Giller E.L., Kosten T.R. Serum testosterone difference between patients with schizophrenia and those with affective disorder. Biol. Psychiatry 1988, 23:357-366.
269. Kaneda Y., Fujii A. Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2000, 24:251-258.
270. Taherianfard M., Shariaty M. Evaluation of serum steroid hormones in schizophrenic patients. Indian J. Med. Sci. 2004, 58:3-9.
271. Dodt C., Dittmann J., Hruby J., Späth-Schwalbe E., Born J., Schüttler R., Fehm H.L. Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type. J. Clin. Endocrinol. Metab. 1991, 72:272-276.
272. Hartmann A., Veldhuis J.D., Deuschle M., Standhardt H., Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normalcontrols: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 1997, 18:285e9.
273. Popp J., Schaper K., Kölsch H., Cvetanovska G., Rommel F., Klingmüller D., Dodel R., Wüllner U., Jessen F. CSF cortisol in Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 2009, 30:498-500.
274. Ferrari E., Arcaini A., Gornati R., Pelanconi L., Cravello L., Fioravanti M., Solerte S.B., Magri F. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp. Gerontol. 2000, 35:1239-1250.
275. Xu J., Xia L.L., Song N., Chen S.D., Wang G. Testosterone, estradiol, and sex hormone-binding globulin in Alzheimer's disease: a meta-analysis. Curr. Alzheimer Res. 2016, 13:215-222.
276. Polleri A., Gianelli M.V., Murialdo G. Dementia: a neuroendocrine perspective. J. Endocrinol. Investig. 2002, 25:73-83.
277. Aldred S., Mecocci P. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. Arch. Gerontol. Geriatr. 2010, 51:e16-e18.
278. Breen D.P., Vuono R., Nawarathna U., Fisher K., Shneerson J.M., Reddy A.B., Barker R.A. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 2014, 71:589-595.
279. Djamshidian A., O'Sullivan S.S., Papadopoulos A., Bassett P., Shaw K., Averbeck B.B., Lees A. Salivary cortisol levels in Parkinson's disease and its correlation to risk behavior. J. Neurol. Neurosurg. Psychiatry 2011, 82:1107-1111.
280. Skogar O., Fall P.A., Hallgren G., Lökk J., Bringer B., Carlsson M., Lennartsson U., Sandbjork H., Törnhage C.J. Diurnal salivary cortisol concentrations in Parkinson's disease: increased total secretion and morning cortisol concentrations. Int. J. Gen. Med. 2011, 4:561-569.
281. Nitkowska M., Tomasiuk R., Czyzyk M., Friedman A. Prolactin and sex hormones levels in males with Parkinson's disease. Acta Neurol. Scand. 2015, 131:411-416.
282. Ready R.E., Friedman J., Grace J., Fernandez H. Testosterone deficiency and apathy in Parkinson's disease: a pilot study. J. Neurol. Neurosurg. Psychiatry 2004, 75:1323-1326.
283. Kenangil G., Orken D.N., Ur E., Forta H., Celik M. The relation of testosterone levels with fatigue and apathy in Parkinson's disease. Clin. Neurol. Neurosurg. 2009, 111:412-414.
284. Mormont M.C., Levi F. Circadian-system alterations during cancer processes: a review. Int. J. Cancer 1997, 70:241-247.
285. Touitou Y., Levi F., Bogdan A., Benavides M., Bailleul F., Misset J.L. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol. 1995, 121:181-188.
286. Sephton S.E., Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?. Brain Behav. Immun. 2003, 17:321-328.
287. Eismann E.A., Lush E., Sephton S.E. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology 2010, 35:963-976.
288. Van der Pompe G., Antoni M.H., Heijnen C.J. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 1996, 21:361-374.
289. Weinrib A.Z., Sephton S.E., Degeest K., Penedo F., Bender D., Zimmerman B., Kirschbaum C., Sood A.K., Lubaroff D.M., Lutgendorf S.K. Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer 2010, 116:4410-4419.
290. Zeitzer J.M., Nouriani B., Neri E., Spiegel D. Correspondence of plasma and salivary cortisol patterns in women with breast cancer. Neuroendocrinology 2014, 100:153-161.
291. Bartsch C., Bartsch H., Flüchter S.H., Mecke D., Lippert T.H. Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients. Consequence of premature aging or of tumor growth?. Ann. N. Y. Acad. Sci. 1994, 719:502-525.
292. Schrepf A., Thaker P.H., Goodheart M.J., Bender D., Slavich G.M., Dahmoush L., Penedo F., DeGeest K., Mendez L., Lubaroff D.M., Cole S.W., Sood A.K., Lutgendorf S.K. Diurnal cortisol and survival in epithelial ovarian cancer. Psychoneuroendocrinology 2015, 53:256-267.
293. Rich T., Innominato P.F., Boerner J., Mormont M.C., Iacobelli S., Baron B., Jasmin C., Lévi F. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastasic colorectal cancer. Clin. Cancer Res. 2005, 11:1757-1764.
294. Sephton S.E., Lush E., Dedert E.A., Floyd A.R., Rebholz W.N., Dhabhar F.S., Spiegel D., Salmon P. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav. Immun. 2013, S163-S170. (Suppl).
295. Cohen L., Cole S.W., Sood A.K., Prinsloo S., Kirschbaum C., Arevalo J.M., Jennings N.B., Scott S., Vence L., Wei Q., Kentor D., Radvanyi L., Tannir N., Jonasch E., Tamboli P., Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One 2012, 7:e42324.
296. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005, 30:92-100.
297. Bower J.E., Ganz P.A., Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom. Med. 2005, 67:277-280.
298. Tell D., Mathews H.L., Janusek L.W. Day-to-day dynamics of associations between sleep, napping, fatigue and the cortisol diurnal rhythm in women diagnosed with breast cancer. Psychosom. Med. 2014, 76:519-528.
299. Lutgendorf S.K., Weinrib A.Z., Penedo F., Russell D., DeGeest K., Costanzo E.S., Henderson P.J., Sephton S.E., Rohleder N., Lucci J.A., Cole S.W., Sood A.K., Lubaroff D.M. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J. Clin. Oncol. 2008, 26:4820-4827.
300. Edgell T., Martin-Roussety G., Barker G., Autelitano D.J., Allen D., Grant P., Rice G.E. Phase II biomarker trial of a multi-marker diagnostic for ovarian cancer. J. Cancer Res. Clin. Oncol. 2010, 136:1079-1088.
301. Lissoni P., Rovelli F., Giani L., Mandala M., Meregalli S., Barni S., Confalonieri G., Bonfanti A. Dehydroepiandrosterone sulfate (DHEAS) secretion in early and advanced solid neoplasms: selective deficiency in metastatic disease. Int. J. Biol. Markers 1998, 13:154-157.
302. Gordon G.B., Bush T.L., Helzlsouer K.J., Miller S.R., Comstock G.W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res. 1990, 50:3859-3862.
303. Kaaks R., Berrino F., Key T., Rinaldi S., Dossus L., Biessy C., Secreto G., Amiano P., Bingham S., Boeing H., de Mesquita H.B.B., Chang-Claude J., Clavel-Chapelon F., Fournier A., van Gils C.H., Gonzalez C.A., Gurrea A.B., Critselis E., Khaw K.T., Krogh V., Lahmann P.H., Nagel G., Olsen A., Onland-Moret N.C., Overvad K., Palli D., Panico S., Peeters P., Quirós J.R., Roddam A., Thiebaut A., Tjønneland A., Chirlaque M.D., Trichopoulou A., Trichopoulos D., Tumino R., Vineis P., Norat T., Ferrari P., Slimani N., Riboli E. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 2005, 97:755-765.
304. Reus V.I., Wolkowitz O.M., Frederick S. Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology 1997, 22(Suppl. 1):S121-S124.
305. Ribeiro M., Ruff P., Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am. J. Clin. Oncol. 1997, 20:605-608.
306. Chen S.S., Chen K.-K., Lin A.T.L., Chang Y.-H., Wu H.H., Chang L.S. The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis. BJU Int. 2002, 89:710-713.
307. Iversen P., Rasmussen F., Christensen I.J. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand. J. Urol. Nephrol. Suppl. 1994, 157:41-47.
308. Carroll T., Findling J. The diagnosis of Cushing's syndrome. Rev. Endocr. Metab. Disord. 2010, 11:147-153.
309. Lacroix A., Feelders R.A., Stratakis C.A., Nieman L.K. Cushing's syndrome. Lancet 2015, 386:913-927.
310. Glass A.R., Zavadil A.P., Halberg F., Cornelissen G., Schaaf M. Circadian rhythm of serum cortisol in Cushing's disease. J. Clin. Endocrinol. Metab. 1989, 59:161-165.
311. Liu J.H., Kazer R.R., Rasmussen D.D. Characterization of the twenty-four hour secretion patterns of adrenocorticotropin and cortisol in normal women and patients with Cushing's disease. J. Clin. Endocrinol. Metab. 1987, 64:1027-1035.
312. Cunningham S.K., McKenna T.J. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome. Clin. Endocrinol. 1994, 41:795-800.
313. Kaltsas G.A., Korbonits M., Isidori A.M., Webb J.A., Trainer P.J., Monson J.P., Besser G.M., Grossman A.B. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?. Clin. Endocrinol. 2000, 53:493-500.
314. Pall M.E., Lao M.C., Patel S.S., Lee M.L., Ghods D.E., Chandler D.W., Friedman T.C. Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome. Horm. Metab. Res. 2008, 40:813-818.
315. Monno S., Tachikawa T., Maekawa T., Sasano H., Sasano A case of Cushing's syndrome due to bilateral cortisol-secreting adenomas with unilateral DHEAS oversecretion. Endocr. J. 2015, 62:283-288.
316. Cutolo M., Villaggio B., Otsa K., Aakre O., Sulli A., Seriolo B. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. Autoimmun. Rev. 2005, 4:497-502.
317. Neeck G., Federlin K., Graef V., Rusch D., Schmidt K.L. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Rheumatol. 1990, 17:24-29.
318. Dekkers J.C., Geenen R., Godaert G.L., van Doornen L.J., Bijlsma J.W. Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43:465-467.
319. Blackman M.R., Muniyappa R., Wilson M., Moquin B.E., Baldwin H.L., Wong K.A., Snyder C., Magalnick M., Alli S., Reynolds J., Steinberg S.M., Goldbach-Mansky R. Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study. Arthritis Res. Ther. 2007, 9:R73.
320. Straub R.H., Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 2007, 56:399-408.
321. Spies C.M., Straub R.H., Cutolo M., Buttgereit F. Circadian rhythms in rheumatology-a glucocorticoid perspective. Arthritis Res. Ther. 2014, 16(Suppl. 2):S3.
322. Cutolo M., Balleari E., Giusti M., Monachesi M., Accardo S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum. 1988, 31:1314-1317.
323. Spector T.D., Perry L.A., Tubb G., Silman A.J., Huskisson E.C. Low free testosterone levels in rheumatoid arthritis. Ann. Rheum. Dis. 1988, 47:65-68.
324. Spector T.D., Ollier W., Perry L.A., Silman A.J., Thompson P.W., Edwards A. Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls. Clin. Rheumatol. 1989, 8:37-41.
325. Tengstrand B., Carlström K., Hafström I. Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years. J. Rheumatol. 2009, 36:887-892.
326. Cutolo M., Straub R.H., Bijlsma J.W.J. Neuroendocrine-immune interactions in synovitis. Nat. Clin. Pract. Rheumatol. 2007, 3:627-634.
327. Cutolo M., Castagnetta L. Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1996, 784:237-251.
328. Straub R.H., Zeuner M., Antoniou E., Schölmerich J., Lang B. Dehydroepi-androsterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J. Rheumatol. 1996, 23:856-861.
329. Straub R.H., Zeuner M., Lock G., Schölmerich J., Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br. J. Rheumatol. 1997, 36:426-432.
330. Crofford L.J., Pillemer S.R., Kalogeras K.T. Hypothalamic-pituitary-adrenal axis perturbations in patients with Fibromyalgia. Arthritis Rheum. 1994, 37:1583-1592.
331. McCain G.A., Tilbe K.S. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J. Rheumatol. 1989, 16(Suppl. 19):154-157.
332. Riva R., Mork P.J., Westgaard R.H., Lundberg U. Fibromyalgia syndrome is associated with hypocortisolism. Int. J. Behav. Med. 2010, 17:223-233.
333. Wingenfeld K., Heim C., Schmidt I., Wagner D., Meinlschmidt G., Hellhammer D.H. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom. Med. 2008, 70:65-72.
334. Fatima G., Das S.K., Mahdi A.A., Verma N.S., Khan F.H., Tiwari A.M., Jafer T., Anjum B. Circadian rhythm of serum cortisol in female patients with fibromyalgia syndrome. Indian J. Clin. Biochem. 2013, 28:181-184.
335. Spencer N.F., Norton S.D., Harrison L.L., Li G.Z., Daynes R.A. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp. Gerontol. 1996, 31:393-408.
336. Straub R.H., Schuld A., Mullington J., Haack M., Schölmerich J., Pollmächer T. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J. Endocrinol. 2002, 175:467-474.
337. Sturgeon J.A., Darnall B.D., Zwickey H.L., Wood L.J., Hanes D.A., Zava D.T., Mackey S.C. Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status. J. Pain Res. 2014, 7:707-716.
338. Yoshikawa G.T., Heymann R.E., Helfenstein M., Pollak D.F. A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression. Rheumatol. Int. 2010, 30:473-478.
339. Vgontzas A.N., Pejovic S., Zoumakis E., Lin H.M., Bixler E.O., Basta M., Fang J., Sarrigiannidis A., Chrousos G.P. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E253-E261.
340. Whitcomb J.E., Findling J.W., Raff H., Harnsher K. Randomized trial of oral hydrocortisone and its effect on emergency physicians during night duty. WMJ 2000, 99:37-41.
341. Vadiraja H.S., Raghavendra R.M., Nagarathna R., Nagendra H.R., Rekha M., Vanitha N., Gopinath K.S., Srinath B.S., Vishweshwara M.S., Madhavi Y.S., Ajaikumar B.S., Ramesh B.S., Nalini R., Kumar V. Effects of a yoga program on cortisol rhythm and mood states in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Integr. Cancer Ther. 2009, 8:37-46.
342. Banasik J., Williams H., Haberman M., Blank S.E., Bendel R. Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors. J. Am. Acad. Nurse Pract. 2011, 23:135-142.
343. Granath J., Ingvarsson S., von Thiele U., Lundberg U. Stress management: a randomized study of cognitive behavioural therapy and yoga. Cogn. Behav. Ther. 2006, 35:3-10.
344. Michalsen A., Grossman P., Acil A., Langhorst J., Lüdtke R., Esch T., Stefano G.B., Dobos G.J. Rapid stress reduction and anxiolysis among distressed women as a consequence of a three-month intensive yoga program. Med. Sci. Monit. 2005, 11:CR555-CR561.
345. Cruess D.G., Antoni M.H., McGregor B.A., Kilbourn K.M., Boyers A.E., Alferi S.M., Carver C.S., Kumar M. Cognitive behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom. Med. 2000, 62:304-308.
346. Raghavendra R.M., Nagarathna R., Nagendra H.R., Gopinath K.S., Srinath B.S., Ravi B.D., Patil S., Ramesh B.S., Nalini R. Effects of an integrated yoga program on chemotherapy-induced nausea and emesis in breast cancer patients. Eur. J. Cancer Care 2007, 16:462-474.
347. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004, 29:448-474.
348. Matousek R.H., Pruessner J.C., Dobkin P.L. Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer. Complement. Ther. Clin. Pract. 2011, 17:65-70.
349. Corey S.M., Epel E., Schembri M., Pawlowsky S.B., Cole R.J., Araneta M.R., Barrett-Connor E., Kanaya A.M. Effect of restorative yoga vs. stretching on diurnal cortisol dynamics and psychosocial outcomes in individuals with the metabolic syndrome: the PRYSMS randomized controlled trial. Psychoneuroendocrinology 2014, 49:260-271.
350. Tortosa-Martínez J., Clow A., Caus-Pertegaz N., González-Caballero G., Abellán-Miralles I., Saenz M.J. Exercise increases the dynamics of diurnal cortisol secretion and executive function in people with amnestic mild cognitive impairment. J. Aging Phys. Act. 2015, 23:550-558.
351. Ho R.T., Wan A.H., Au-Yeung F.S., Lo P.H., Siu P.J., Wong C.P., Ng W.Y., Cheung I.K., Ng S.M., Chan C.L., Chen E.Y. The psychophysiological effects of Tai-chi and exercise in residential schizophrenic patients: a 3-arm randomized controlled trial. BMC Complement. Altern. Med. 2014, 14:36.
352. Ho R.T., Cheung J.K., Chan W.C., Cheung I.K., Lam L.C. A 3-arm randomized controlled trial on the effects of dance movement intervention and exercises on elderly with early dementia. BMC Geriatr. 2015, 15:127.
353. Saxton J.M., Scott E.J., Daley A.J., Woodroofe M., Mutrie N., Crank H., Powers H.J., Coleman R.E. Effects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial. Breast Cancer Res. 2014, 16:R39.